|
1. Al Henawy SI, Al Daghri NM, Helmy NM. Immunoglobulin and activities of lactate dehydrogenase and alkaline phosphates on the serum of some Saudi mother and neonate. The Second National Meeting of Chemists, March 1987, Saudi Arabia.
2. Al Attas OS, Al Daghri NM. Placental insulin binding in women at high risk of developing gestational diabetes mellitus: Effect of familial history of diabetes mellitus as risk factor. Diabetes, Nutrition and Metabolism 1995; 8:744-80.
3. Al-Attas OS, Al Dagheri NM, Vigo NT. Vanadate enhances insulin-receptor binding in gestational diabetic placenta. Cell Biochem and Function 1995; 13:9-14. [Pubmed]
4. Al Senaidy A, Al Attas OS, Al Daghri NM. Plasma a and b tocopherol levels during pregnancy in women with GDM and women at high risk of developing GDM. Med Sci Res 1995; 23: 171-174.
5. Al-Nuaim AR, Al-Rubeaan K, Al-Mazrou Y, Al-Attas O, Al-Daghari N, Khoja T. High prevalence of overweight and obesity in Saudi Arabia. Int J. Obesity 1996; 20: 457-552. [Pubmed]
6. Al-Nuaim AR, Al-Rubeaan K, Al-Mazrou Y, Al-Attas O, Al-Daghari N. Prevalence of hypercholesterolemia in Saudi Arabia , epidemiological study. Int J Cardiol 1996; 54:41d-49. [Pubmed] [Science Direct]
7. Al Nuaim AR, Al-Rubeaan K, Al-Mazrou Y, Al-Attas O, Al- Daghari N. Serum total, fractionated cholesterol concentration distribution and prevalence of hypercholesterlemia in Saudi Arabia, regional variation. Ann. Saudi Med 1997; 17(2): 179-84. [Pubmed]
8. Al-Nuaim AR, Al-Mazrou Y, Kamel M, Al-Attas O, Al-Daghari N, Sulimani R. Iodine deficiency in Saudi Arabia. Ann Saudi Med 1997; 17(3): 293-7. [Pubmed]
9. Al-Nuaim AR, Mirdad S, Al-Rubeaan K, al-Mazrou Y, al-Attas O, al-Daghari N, Khoja T. Population-based epidemiological study on characteristic of risk factors of hypercholesterolemia in Saudi Arabia. Int J Cardiol 1997; 62(1): 47-54. [Pubmed][Science Direct]
10. Al-Nuaim AR, Mirdad S, Al-Rubeaan K, Al-Mazrou Y, Al-Attas O, Al-Daghari N. Pattern and factors associated with glycemic control of Saudi diabetic patients. Ann Saudi Med 1998; 18(2): 109-12. [Pubmed]
11. Al-Nozah M, Al-Daghri N, Bartlett WA, Al-Attas O, Al-Maatouq M, Martin SC, Kumar S, Jones AF. Serum homocysteine concentration is related to diabetes mellitus, but not to coronary heart disease, in Saudi Arabians. Diabetes Obes Metab 2002; 4(2):118-23. [Pubmed] [Blackwell Synergy]
12. Al-Daghri N, Bartlett WA, Jones AF, Kumar S. Role of leptin in glucose metabolism in type 2 diabetes. Diabetes Obes Metab 2002; 4(3):147-55. [Pubmed] [Blackwell Synergy]
13. Al-Daghri N, Al-Rubean K, Bartlett WA, Al-Attas O, Jones AF, and Kumar S. Serum leptin is elevated in Saudi Arabian patients with metabolic syndrome and coronary artery disease. Diabet Med 2003; 10:832-837. [Pubmed] [Blackwell Synergy]
14. Al-Daghri N, Al-Attas O, Patel A, Belyaev ND, Bartlett WA, Jones AF, Kumar S, Bain SC. Association between Taq IB cholesterol ester transfer protein polymorphism and low HDL cholesterol concentrations in Saudis. Clin Sci (Lond) 2003; 105 (4): 467-472. [Pubmed] [Clinical Science]
15. Valsamakis G, Chetty R, McTernan PG, Al-Daghri NM, Barnett AH, Kumar S. Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol. Diabetes Obes Metab 2003; 5(2):131-5. [Pubmed] [Blackwell Synergy]
16. Valsamakis G, McTernan PG, Chetty R, Al Daghri N, Field A, Hanif W, Barnett AH, Kumar S . Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism 2004; 53(4):430-4. [Pubmed][Blackwell Synergy]
17. Al-Daghri N, Chetty R, McTernan PG, Al-Rubean K, Al-Attas O, Jones AF, Kumar S. Serum resistin is associated with C-reactive protein and LDL- cholesterol in type 2 diabetes and coronary artery disease in a Saudi population. Cardiovasc Diabetol 2005; 4:10 (5 July 2005). [Pubmed] [Biomed Central]
18. Wasim H, Al-Daghri NM, Chetty R, McTernan PG, Barnett AH, and Kumar S. Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in South Asians. Cardiovasc Diabetol 2006; 5-10. [Pubmed] [Biomed Central]
19. Al-Daghri NM. The association of endothelial constitutive nitric oxide synthase polymorphisms with family history of coronary heart disease in men. Gene Ther Mol Biol 2006; 10: 193-198. [Gene Therapy and Molecular Biology]
20. Al-Daghri NM. Hyperhomocystenemia, coronary heart disease, and diabetes mellitus as predicted by various definitions for metabolic syndrome in a hypertensive Saudi population. Saudi Med J 2007; 28(3): 339-46. [Pubmed]
21. Al-Daghri NM, Al-Attas OS, Al-Rubeaan K. The atherogenic and metabolic impact on non-HDL cholesterol versus other lipid subcomponents among non-diabetic and diabetic Saudis. Lipids Health Dis 2007; 6(1):9. [Pubmed] [Biomed Central]
22. Al-Daghri N, Al-Attas O, Al-Rubeaan K, Mahieldin M, Al-Katari M, Jones AF, Kumar S. Serum leptin and its association to anthropometric measures of obesity in pre-diabetic Saudis. Cardiovasc Diabetol 2007; 6:18. [Pubmed] [Biomed Central]
23. Al-Daghri NM, Al-Attas O, Al-Rubeaan K, Sallam R. Adipocytokine profile of type 2 diabetics in metabolic syndrome as defined by various criteria. Diabet Metab Res Rev 2008; 24(1): 52-8. [Pubmed] [Wiley Interscience]
24. Alsmadi O, Al-Rubeaan K, Wakil SM, Imtiaz F, Mohamed G, Al-Saud H, Al-Saud NA, Aldaghri N, Mohammad S, Meyer BF. Genetic Study of Saudi Diabetes (GSSD): significant association of the KCNJ11 E23K polymorphism with type 2 diabetes. Diabetes Metab Res Rev 2008; 24(2): 137-40. [Pubmed] [Wiley Interscience]
25. Al-Daghri NM, Al-Attas O. Homocysteinemia, hypertension and family history of diabetes in a smoking Saudi male population. Cent Eur J Med 2008; 3(2): 167-172. [Springerlink]
26. Al-Daghri NM, Al-Attas O, Al-Onazi M, Al-Rubeaan K, Al-Najjar H. Adipocytokines as influenced by family history of type 2 diabetes and smoking in non-diabetic subjects. Clinical Medicine: Endocrinology and Diabetes 2008; 1:13-19. [Libertas Academica]
27. Alfadda A, Al-Daghri N, Malabu U. Apolipoprotein B/A1 in relation to metabolic syndrome in type 2 diabetes mellitus. Saudi Med J 2008; 29 (6):821-5. [Pubmed]
28. Al-Rubeaan K, Al-Daghri NM, Alkharfy KM, Al-Attas OS, Hanif FS, Metias NS, Sabico SL. Bioequivalence of Jusline following subcutaneous administration in healthy subjects. Int J Clin Pharmacol Ther 2008; 46(7): 382-388. [Pubmed]
29. Al-Daghri NM. The role of clinical laboratories in understanding the obesity epidemic in the Middle-East: The King Saud University Diabetes and Endocrinology Research Center experience. Med Lab Magazine 2008; Issue 1: 10-11. [ArabHealth on-line]
30. Al-Daghri NM. Hormones. Encyclopedia of Obesity 1st ed. By Keller, SAGE Publications 2008; Vol.1: pp 366-367.
31. Al-Daghri NM. Advancements in obesity management: leptin and adiponectin patents. Recent Patents on Endocrine, Metabolic, & Immune Drug Discovery 2008; 2(3): 200-203. [ingenta connect]
32. Alsmadi O, Al-Rubeaan K, Mohamed G, Alkayal F, Al-Saud H, Abu Al-Saud N, Al-Daghri N, Mohammad S, Meyer BF. Weak or no association of TCF7L2 variants with Type 2 diabetes risk in an Arab population. BMC Med Genet 2008; 9(1):72. [Pubmed] [Biomed Central]
33. Al-Daghri NM. Serum Polycyclic Aromatic Hydrocarbons among children with and without asthma: correlation to environmental and dietary factors. Int J Occup Environ Health; 2008; 21(3):211-7. [Pubmed]
|